Blood test catches cancer early; drug aims to stop return
Disease control
Not yet recruiting
This study tests whether monitoring tumor DNA in the blood (ctDNA) and treating with abemaciclib can prevent breast cancer from coming back. 30 people with HR+/HER2- breast cancer who have finished standard treatment will be followed. If ctDNA is detected, they will receive abema…
Phase: PHASE2 • Sponsor: Nagoya City University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC